Nationwide
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
BioNTech SE
Ph 3·4 sites in DC, FL, NV +1
Enrolling now
Check if I qualifyShowing 1–24 of 99 trials
BioNTech SE
Context Therapeutics Inc.
Memorial Sloan Kettering Cancer Center
Daiichi Sankyo
Iovance Biotherapeutics, Inc.
MacroGenics
858 Therapeutics, Inc.
Sutro Biopharma, Inc.
Totus Medicines
BeiGene
Northwestern University
ModeX Therapeutics, An OPKO Health Company
Medtronic - MITG
Jonsson Comprehensive Cancer Center
University of California, San Francisco
Rachel Miller
National Cancer Institute (NCI)